MedPath
NMPA Approval

炔孕酮

国药准字H11021733

August 16, 2020

国药准字H11021733

Drug Information

炔孕酮

原料药

化学药品

August 16, 2020

Company Information

Applicant Company

Manufacturing Company

河北省秦皇岛市经济技术开发区龙海道10号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

炔孕酮 - NMPA 批准文号 | MedPath